Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Repligen is a global life sciences company specializing in innovative bioprocessing technologies and systems that enhance the efficiency, scalability, and flexibility of biologic drug manufacturing. Its core offerings include filtration, chromatography, process analytics, and proteins, serving biopharmaceutical, gene therapy, and vaccine markets. The company focuses on integrated solutions, continuous innovation, and strategic acquisitions to support biologics, mRNA, and gene therapy production worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.